Killer Immunoglobulin-Like Receptor-Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (4) , 672-682
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Cancer Institute
This publication has 40 references indexed in Scilit:
- Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and TreatmentInternational Journal of Molecular Sciences, 2019
- Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor–Recipient PairsTransplantation and Cellular Therapy, 2016
- Impact of “Killer Immunoglobulin-Like Receptor /Ligand” Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free SurvivalPLOS ONE, 2015
- Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantationCytotherapy, 2012
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1New England Journal of Medicine, 2012
- Killer cell immunoglobulin‐like receptors on NK cells: the how, where and whyInternational Journal of Immunogenetics, 2007
- Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCTBlood, 2007
- Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantationClinical and Experimental Immunology, 2007
- Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypesBlood, 2005
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002